<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00932516</url>
  </required_header>
  <id_info>
    <org_study_id>07SWHK-NONDIABETIC</org_study_id>
    <nct_id>NCT00932516</nct_id>
  </id_info>
  <brief_title>Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to a Calorie-Restricted Diet in Women</brief_title>
  <official_title>The Effect of South Beach Diet™ Using South Beach Diet™ Products Compared to a Traditional Calorie-Restricted Diet in Non-Diabetic Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mondelēz International, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KGK Science Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Mondelēz International, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the effectiveness of the South Beach Diet™ and South&#xD;
      Beach Diet™ products compared to a traditional calorie restricted diet.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in body weight from baseline to week 24</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess the satiety response to the individual diets</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analyze circumference measurements &amp; body composition; blood glucose, HbA1c, insulin, lipid profile, blood pressure &amp; questionnaire responses on food cravings and quality of life</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">248</enrollment>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>South Beach Diet™ with SBD™ Products</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>South Beach Diet™ alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Calorie restricted diet w/ SBD™ Products</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Calorie Restricted Diet alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>South Beach Diet™ with South Beach Diet™ Products</intervention_name>
    <arm_group_label>South Beach Diet™ with SBD™ Products</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>South Beach Diet™</intervention_name>
    <arm_group_label>South Beach Diet™ alone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Calorie restricted diet with South Beach Diet™ Products</intervention_name>
    <arm_group_label>Calorie restricted diet w/ SBD™ Products</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Calorie Restricted Diet</intervention_name>
    <arm_group_label>Calorie Restricted Diet alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Female age 18 to 55 years&#xD;
&#xD;
          2. Females of childbearing potential must agree to use a medically approved method of&#xD;
             birth control and have a negative urine pregnancy test result&#xD;
&#xD;
          3. Healthy as determined by laboratory results and medical history&#xD;
&#xD;
          4. Waist circumference &gt; 87 cm&#xD;
&#xD;
          5. Stable weight defined as &lt; 4.5 kg gained or lost in past 3 months&#xD;
&#xD;
          6. Agreement to maintain current level of physical activity throughout the study&#xD;
&#xD;
          7. Ability to comprehend and complete the questionnaires and forms&#xD;
&#xD;
          8. Agreement to comply with study procedures, test article consumption and has access to&#xD;
             a microwave oven&#xD;
&#xD;
          9. Voluntary, written, informed consent to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnant, breastfeeding, or planning to become pregnant during the course of the trial&#xD;
&#xD;
          2. Use of prescription or over the counter products known to effect weight including but&#xD;
             not limited to the following: megestrol acetate; somatropin; sibutramine; orlistat;&#xD;
             paroxetine; dextroamphetamine; methylphenidate; atomoxetine; quetiapine; olanzepine;&#xD;
             risperidone, within 4 weeks of randomization and during the trial&#xD;
&#xD;
          3. Alcohol use &gt; 2 standard alcoholic drinks per day&#xD;
&#xD;
          4. Significant cardiac history defined as a history of myocardial infarction (MI);&#xD;
             coronary angioplasty or bypass graft(s); valvular disease or repair; unstable angina&#xD;
             pectoris; transient ischemic attack (TIA); cerebrovascular accidents (CVA); congestive&#xD;
             heart failure; or coronary artery disease (CAD)&#xD;
&#xD;
          5. History of or current diagnosis of any cancer (except for successfully treated basal&#xD;
             cell carcinoma) diagnosed less than 5 years prior to screening Subjects with cancer in&#xD;
             full remission for more than 5 years are acceptable&#xD;
&#xD;
          6. Uncontrolled hypertension defined as untreated systolic blood pressure &gt; 160 mmHg&#xD;
             and/or diastolic blood pressure &gt; 100 mmHg&#xD;
&#xD;
          7. Diabetes mellitus Type I or Type II&#xD;
&#xD;
          8. Unstable renal and/or liver disease&#xD;
&#xD;
          9. History of alcohol or drug abuse within the past year&#xD;
&#xD;
         10. Unstable psychiatric disorder requiring hospitalization within the past 6 months&#xD;
&#xD;
         11. Immunocompromised individuals such as subjects that have undergone organ&#xD;
             transplantation or subjects diagnosed with human immunodeficiency virus (HIV)&#xD;
&#xD;
         12. History of hemoglobinopathies such as sickle cell anemia or thalassemia, sideroblastic&#xD;
             anemia&#xD;
&#xD;
         13. Participation in another clinical research trial within 30 days prior to randomization&#xD;
             and during the trial&#xD;
&#xD;
         14. Significant abnormal liver function as defined as AST and/or ALT &gt; 2 x ULN, and/or&#xD;
             bilirubin &gt; 2 x ULN&#xD;
&#xD;
         15. Serum creatinine &gt; 125 umol/L&#xD;
&#xD;
         16. Anemia of any etiology defined as hemoglobin &lt; 110 g/L&#xD;
&#xD;
         17. Uncontrolled and/or untreated thyroid disorder&#xD;
&#xD;
         18. Unstable medications (Dosage must be stable for 90 days prior to randomization)&#xD;
&#xD;
         19. History of food allergies or sensitivities including lactose intolerance&#xD;
&#xD;
         20. Vegetarians&#xD;
&#xD;
         21. Cognitively impaired and/or unable to give informed consent&#xD;
&#xD;
         22. Any other condition which in the Investigator's opinion may adversely affect the&#xD;
             subject's ability to complete the study or its measures or which may pose significant&#xD;
             risk to the subject&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Crowley, MD</last_name>
    <role>Study Director</role>
    <affiliation>KGK Science Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medicus Research</name>
      <address>
        <city>Northridge</city>
        <state>California</state>
        <zip>91325</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SIBR Research</name>
      <address>
        <city>Bradenton</city>
        <state>Florida</state>
        <zip>34205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miami Research Associates</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chase Wellness &amp; Research Center</name>
      <address>
        <city>Virginia Beach</city>
        <state>Virginia</state>
        <zip>23455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <study_first_submitted>June 30, 2009</study_first_submitted>
  <study_first_submitted_qc>July 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 3, 2009</study_first_posted>
  <last_update_submitted>July 2, 2009</last_update_submitted>
  <last_update_submitted_qc>July 2, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 3, 2009</last_update_posted>
  <responsible_party>
    <name_title>Richard Black, PhD/VP, Nutrition</name_title>
    <organization>Kraft Foods</organization>
  </responsible_party>
  <keyword>South Beach Diet™</keyword>
  <keyword>overweight</keyword>
  <keyword>obesity</keyword>
  <keyword>satiety</keyword>
  <keyword>weight loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

